Disc Medicine Launches $350 Million Stock and Pre-Funded Warrant Offering
Bitget2026/10/19 20:02- Disc Medicine launched a proposed $350 million underwritten public offering of common stock or, at certain investors' option, pre-funded warrants.
- Underwriters would receive a 30-day option to purchase up to $52.5 million in additional common stock.
- Proceeds would fund research and clinical development, potential bitopertin commercialization, other pre-commercialization activities and general corporate purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

The AI arms race extends upstream! Reports say Intel, Nvidia, and AMD are prepaying over 100 billions NTD to secure advanced IC substrate production capacity.
NVIDIA, Intel, and AMD have collectively spent $5 billion in advance payments to aggressively secure high-end IC substrates from Taiwan. Driven by "big money for guaranteed orders," the top three Taiwanese substrate manufacturers have invested a record NT$161.2 billion to expand their production capacity. The tech giants' substantial financial commitments to secure supply chains highlight the intense competition and extreme scarcity of core AI materials.


Brent Crude Oil Hits $116 as Markets Weigh Another Inflation Shock
